Improvements seen in cognition, cholesterol, blood sugar, and C-reactive protein
Association between schizophrenia and cardiovascular disease events more pronounced in women than men
However, neurocognitive declines are seen in others, which is tied to other poor outcomes
Significant improvements seen at eight months for positive symptoms and hallucinations, delusions
Reduction in 30-day readmission rate seen for schizophrenia or schizoaffective disorder with long-acting versus oral antipsychotics
In a recent study, severe QT prolongation occurred in 13.0 percent of quetiapine and 14.2 percent of haloperidol users
Researchers found that few individuals with psychotic disorders have participated in vocational training
74.9 additional visits for schizophrenia spectrum disorders seen at three months after initial phase of COVID-19 pandemic
Twenty transcranial magnetic stimulation treatments over four weeks result in improvement in event-based prospective memory
Findings show dose-response relationship, with highest risk for autism, intellectual disability, tic disorder, depression, biopolar disorder